Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Dec 2016 12:55

RNS Number : 8487Q
Polypipe Group PLC
02 December 2016
 

 

Polypipe Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that today, 2 December 2016, Martin Payne, a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 50,601 ordinary shares of £0.001 each in the capital of the Company ('Shares'), in accordance with the Deferred Share Award that was granted to him on 31 May 2016, full details of which were included in a regulatory announcement released on 31 May 2016. The Company's Employee Benefit Trust has today transferred 26,819 Shares to Mr. Payne which represents the net number of Shares due to him after appropriate tax and national insurance liabilities were taken into account. Mr. Payne now holds an interest in a total of 56,819 Shares in the Company.

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options granted as a Deferred Share Award on 31 May 2016.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

50,601 - Number of Shares vesting and over which options were exercised.

 

26,819 -Shares acquired after reduction for appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 December 2016

f)

 

Place of the transaction

 

 

Outside of a Trading Venue

 

Enquiries:

David Hall, Chief Executive Officer

Martin Payne, Chief Financial Officer

+44 (0) 1709 772284

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKBDPBBDDNBK
Date   Source Headline
6th Apr 20213:30 pmRNSChange of Name
16th Mar 20217:00 amRNSFinal Results
11th Mar 20213:17 pmRNSHolding(s) in Company
5th Mar 20214:17 pmRNSHolding(s) in Company
3rd Mar 20219:24 amRNSHolding(s) in Company
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20214:58 pmRNSTotal Voting Rights
17th Feb 20218:05 amRNSHolding(s) in Company
15th Feb 20214:22 pmRNSDirector/PDMR Shareholding
15th Feb 20211:59 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSResults of placing
10th Feb 20214:52 pmRNSProposed placing of new ordinary shares
10th Feb 20214:50 pmRNSAcquisition of ADEY
2nd Feb 20217:00 amRNSAcquisition of Nu-Heat and Trading Update
1st Feb 20213:57 pmRNSHolding(s) in Company
29th Jan 20215:32 pmRNSHolding(s) in Company
8th Jan 20218:50 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSTrading Update
24th Nov 20208:25 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSTrading Update
2nd Nov 20202:31 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:05 amRNSBlock listing Interim Review
30th Oct 20204:26 pmRNSTotal Voting Rights
29th Oct 20202:32 pmRNSDirector/PDMR Shareholding
19th Oct 202010:09 amRNSHolding(s) in Company
7th Oct 202012:28 pmRNSHolding(s) in Company
6th Oct 202010:19 amRNSHolding(s) in Company
23rd Sep 202010:43 amRNSDirector Declaration
22nd Sep 20203:59 pmRNSDirector/PDMR Shareholding
17th Sep 20204:21 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
17th Jul 20204:26 pmRNSNon-Executive Director update
16th Jul 20209:37 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSCOVID-19 Update
30th Jun 20202:41 pmRNSTotal Voting Rights
29th Jun 202012:59 pmRNSDirector Declaration
26th Jun 20204:19 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:57 pmRNSDirector/PDMR Shareholding
23rd Jun 20208:28 amRNSHolding(s) in Company
22nd Jun 20204:14 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
22nd Jun 20203:06 pmRNSNon-Executive Director changes
18th Jun 20204:14 pmRNSDirector/PDMR Shareholding
17th Jun 20208:18 amRNSHolding(s) in Company
3rd Jun 202011:17 amRNSHolding(s) in Company
1st Jun 20201:24 pmRNSTotal Voting Rights
21st May 20203:05 pmRNSResult of AGM
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202010:14 amRNSDirector/PDMR Shareholding
12th May 20204:01 pmRNSAnnual General Meeting 2020 - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.